Jakarta (ANTARA) – Consistent downstreaming will help strengthen the exports of industrially processed goods and reduce the dominance of oil and gas exports, Trade Minister Muhammad Lutfi has said. “We export 76.49 percent of industry-processed products. This will be bigger in the future as oil and gas (goods) would be reduced in
Yogyakarta (ANTARA) – Yogyakarta Mayor Haryadi Suyuti has asked residents to comply with regulations promulgated under Level 3 community activity restrictions (PPKM) to curb the spread of COVID-19 in the city. “We have to learn from our experience facing the second wave in June–October last year. It takes about four
Jakarta (ANTARA) – The Jakarta provincial government has urged residents who have received the ticket for the third or booster vaccination to get inoculated without “vaccine shopping,” that is forgoing vaccines if they do not belong to their preferred brand. The government is currently ramping up booster vaccinations to suppress
Jakarta (ANTARA) – The pre-employment card program has had a positive impact on beneficiaries, particularly in relation to entrepreneurial competence, financial industry, financial security, and food management, Coordinating Minister for Economic Affairs, Airlangga Hartarto, has said. The impact of the pre-employment card is evident from the results of independent research
Jakarta (ANTARA) – The COVID-19 positivity rate among health workers is currently high, spokesperson for the Ministry of Health, Siti Nadia Tarmizi, has informed. “The positivity rate of our health workers is high. On average, there are five health workers testing positive out of eight (health workers) tested,” she told ANTARA here
Global CDMO’s Heidelberg Facility Supplies more pDNA material to help address growing needs Heidelberg, Germany, Feb. 08, 2022 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded partnership to supply more plasmid DNA (pDNA) starting material for the Pfizer-BioNTech COVID-19 vaccine